Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Icell Gene Therapeutics

Clinical trials sponsored by Icell Gene Therapeutics, explained in plain language.

Trials to join now! 1 Not yet recruiting 1

New Two-Pronged cell therapy aims to outsmart tough blood cancers

Disease control Recruiting now

This early-phase study is testing the safety of a new type of CAR T-cell therapy called BCMA-CD19 cCAR in patients with advanced multiple myeloma or plasmacytoid lymphoma who have no other treatment options left. The therapy uses a patient's own modified immune cells to attack ca…

Phase: PHASE1 • Sponsor: iCell Gene Therapeutics • Aim: Disease control

Last updated Apr 04, 2026 03:19 UTC